THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 20 filers reported holding THERAVANCE INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $36,000 | -21.7% | 37,000 | -21.3% | 0.00% | – |
| Q2 2022 | $46,000 | -11.5% | 47,000 | 0.0% | 0.00% | – |
| Q1 2022 | $52,000 | +2.0% | 47,000 | 0.0% | 0.00% | – |
| Q4 2021 | $51,000 | +15.9% | 47,000 | +14.6% | 0.00% | – |
| Q3 2021 | $44,000 | -91.9% | 41,000 | -92.3% | 0.00% | – |
| Q2 2021 | $543,000 | -10.8% | 534,000 | -12.3% | 0.00% | – |
| Q1 2021 | $609,000 | +26.1% | 609,000 | +26.9% | 0.00% | – |
| Q4 2020 | $483,000 | +150.3% | 480,000 | +137.6% | 0.00% | – |
| Q3 2020 | $193,000 | +160.8% | 202,000 | +152.5% | 0.00% | – |
| Q1 2020 | $74,000 | +124.2% | 80,000 | +142.4% | 0.00% | – |
| Q4 2019 | $33,000 | -91.5% | 33,000 | -91.9% | 0.00% | – |
| Q2 2018 | $390,000 | +174.6% | 405,000 | +204.5% | 0.00% | – |
| Q1 2018 | $142,000 | +230.2% | 133,000 | +209.3% | 0.00% | – |
| Q4 2017 | $43,000 | -98.5% | 43,000 | -98.7% | 0.00% | -100.0% |
| Q2 2017 | $2,945,000 | +13.1% | 3,236,000 | +18.0% | 0.00% | – |
| Q1 2017 | $2,604,000 | – | 2,742,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 41,771 | $44,921,000 | 2.37% |
| LINDEN ADVISORS LP | 45,495,000 | $48,853,000 | 1.16% |
| BASSO CAPITAL MANAGEMENT, L.P. | 4,759,000 | $5,092,000 | 0.94% |
| SSI INVESTMENT MANAGEMENT LLC | 6,850,000 | $7,332,000 | 0.60% |
| TEALWOOD ASSET MANAGEMENT INC | 1,390,000 | $1,492,000 | 0.59% |
| Castle Creek Arbitrage, LLC | 6,070,000 | $6,516,000 | 0.48% |
| OAKTREE CAPITAL MANAGEMENT LP | 21,717,000 | $23,355,000 | 0.37% |
| AQR Arbitrage LLC | 27,018,000 | $29,055,000 | 0.34% |
| CSS LLC/IL | 5,000,000 | $5,360,000 | 0.27% |
| CQS Cayman LP | 4,150,000 | $4,469,000 | 0.21% |